Guillaume Pfefer
Algemeen Directeur bij Sail Biomedicines
Profiel
Guillaume Pfefer is the founder of Sail Biomedicines.
He is currently the CEO-Partner at Flagship Pioneering.
Previously, he served as Co-President & Chief Executive Officer at KALA BIO, Inc., President, Chief Executive Officer & Treasurer at Senda Biosciences, Inc., Principal at Aventis SA and Rhone-Poulenc SA, and Vice President & Global Head-Corporate Strategy at Sanofi Pasteur SA de CV.
Pfefer holds a doctorate from Université de Lorraine and an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Guillaume Pfefer
| Bedrijven | Functie | Begin |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01-06-2020 |
Sail Biomedicines
 Sail Biomedicines Pharmaceuticals: MajorHealth Technology Sail Biomedicines was founded in 2023 by Guillaume Pfefer. The American company engages in the design and deployment of programmable medicines. Guillaume Pfefer has been the CEO since 2023. | Algemeen Directeur | - |
Eerdere bekende functies van Guillaume Pfefer
| Bedrijven | Functie | Einde |
|---|---|---|
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Algemeen Directeur | - |
| Rhone-Poulenc SA | Corporate Officer/Principal | - |
Sanofi Pasteur SA de CV
 Sanofi Pasteur SA de CV BiotechnologyHealth Technology Part of Sanofi, Sanofi Pasteur SA de CV is a Mexican company that develops, manufactures and supplies vaccines. The company is based in Coyoacán, Mexico. | Corporate Officer/Principal | - |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Corporate Officer/Principal | - |
| KALA BIO, INC. | Algemeen Directeur | - |
Opleiding van Guillaume Pfefer
| Université de Lorraine | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Rhone-Poulenc SA | Process Industries |
Sanofi Pasteur SA de CV
Sanofi Pasteur SA de CV BiotechnologyHealth Technology Part of Sanofi, Sanofi Pasteur SA de CV is a Mexican company that develops, manufactures and supplies vaccines. The company is based in Coyoacán, Mexico. | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Sail Biomedicines was founded in 2023 by Guillaume Pfefer. The American company engages in the design and deployment of programmable medicines. Guillaume Pfefer has been the CEO since 2023. | Health Technology |
